Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
MSCA Postdoctoral Fellowships @Sorbonne Université and its Alliance partners - Call for Applications
://www.sorbonne-universite.fr/en/news/msca-postdoctoral-fellowships-sorbonne-university-2026 2. Prepare your CV, a motivation letter and fill in the required online application before April, 24th on https://msca
-
cancer, we have developed a comprehensive pipeline going from molecular genetics to the clinic. The Brugarolas lab is also the hub of the Kidney Cancer Program (https://kcp.utsw.edu/ ), one of two
-
in education, patient care, community service, research and technology development, and through leadership activities in Michigan, nationally and internationally. Our mission is guided by our
-
, cancerous or developmental diseases. Under the supervision of SysMics scientific leaders, we expect junior postdoctoral fellows to develop their own research projects while acquiring additional academic
-
the Shaul/Mineo lab receive strong support from both of the PI’s, who are committed to their professional development in preparation for academic, industrial, or entrepreneurial careers in cardiovascular
-
of Health (NIH) and the Department of Health and Human Services (DHHS). Within this program, the Section on Synapse Development Plasticity (Chief: Zheng Li, PhD, https://www.nimh.nih.gov/research/research
-
system and its repurposing into a tool for genome editing, a method developed at Umeå University that was awarded the 2020 Nobel Prize in Chemistry. The host lab is located within the cross-disciplinary
-
addresses fundamental questions in biological mechanisms, pharmacology, cell and developmental biology, and agrosciences to understand the roles & regulatory principles of biological networks in
-
to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with
-
(http://vanallenlab.dana-farber.org/) to work on the analysis of new datasets generated in the context of multiple clinically oriented cancer sequencing projects in order help advance efforts